The pharmaceutical world is observing a remarkable shift in glucose therapy with the arrival of GLP-1 patches. These systems offer a potentially more convenient alternative to injections of GLP-1 receptor agonists, minimizing the requirement of daily needle pricks. The technology releases the dru